title: Hepatitis B surface antigen-positive organ transplantation recipients: can lamivudine alter their fate?
authors.forename: N
authors.initials: N
authors.lastname: Leung
mesh_terms: D002353:Carrier State / Q000188:drug therapy* / Q000276:immunology; D018450:Disease Progression; D006509:Hepatitis B / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008111:Liver Function Tests; D016377:Organ Transplantation; D011183:Postoperative Complications / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D015996:Survival Rate; D014181:Transplantation Immunology; D016896:Treatment Outcome; D014775:Virus Activation / Q000187:drug effects* / Q000276:immunology
chemical_list: D006514:Hepatitis B Surface Antigens; D019259:Lamivudine